Oxidative Stress and Bisphenol A (BPA) Impact With Polycystic Ovary Syndrome (PCOS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01600872|
Recruitment Status : Unknown
Verified November 2013 by Ming-I Hsu, Taipei Medical University WanFang Hospital.
Recruitment status was: Recruiting
First Posted : May 17, 2012
Last Update Posted : November 6, 2013
Both oxidative stress and Bisphenol A (BPA) had been associated with polycystic ovary syndrome (PCOS). BPA, one of endocrine-disrupting chemicals (EDCs), is an environmental estrogen used in the synthesis of plastics, is a "high-volume production" chemical with widespread human exposure. BPA was been reported in several female reproductive disturbance. However, the pathological pathway of BPA impact on female reproductive system had not been well-understood. Reactive oxygen species (ROS) have a role in the modulation of gamete quality and gamete interaction. Persistent and elevated generation of ROS leads to a disturbance of redox potential that in turn causes oxidative stress (OS). The first part of The investigators study is aim to evaluate the oxidative stress impact on the biochemical parameters in women with PCOS; the secondary part of the investigators study is to investigate the BPA on the clinical and biochemical of women with PCOS; finally, the investigators plan to test the hypothesis that BPA might increase oxidative stress and then elevated ROS in women with menstrual disturbance, furthermore, the role of oxidative stress and BPA impact on insulin resistance and metabolic disturbance will be also investigated.
Study and control cases will be included. Serum total oxidant status (TOS), total antioxidant status (TAS), Bisphenol A (BPA), and clinical/biochemical parameters will be obtained for all cases. Oxidative stress and BPA will be evaluated with all clinical/biochemical parameters for all subjects.
|Condition or disease|
|Oxidative Stress Endocrine Disrupting Chemicals Polycystic Ovary Syndrome|
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Official Title:||Oxidative Stress and BPA Impact With PCOS|
|Study Start Date :||March 2012|
|Estimated Primary Completion Date :||April 2014|
|Estimated Study Completion Date :||April 2014|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01600872
|WanFang Medical Center at Taipei Medical University||Recruiting|
|Taipei City, Taiwan, 116|
|Contact: Ming I Hsu, MD 886-2-29307930 ext 2508 email@example.com|
|Principal Investigator: Ming I Hsu, MD|
|Principal Investigator:||Ming I Hsu, MD||Taipei Medical University WanFang Hospital|